The latest company cofounded by the prolific MIT scientist and entrepreneur Robert Langer has raised $11 million to advance work on a new kind of surgical adhesive technology.
The startup called Gecko Biomedical grew out of the Langer Lab at the Massachusetts Institute of Technology and is now based in France. It aims to bring its biodegradable glues and patches to market in the next few years for surgeons to close up wounds after operations.
For decades, Langer has been helping turn these kinds of medical breakthroughs into new companies. In fact, he has cofounded 26 companies that, among other things, are now helping fight cancer, treat spinal cord injuries, and combat heart disease. One of those startups, Bind Therapeutics Inc. of Cambridge, went public in August. Full story for BostonGlobe.com subscribers.
Michael B. Farrell can be reached at email@example.com.